Hasten - Crunchbase Company Profile & Funding

Q: Where is Hasten's headquarters?

Hasten is located in Hefei, Anhui, China.

Q: Who invested in Hasten?

Hasten has 2 investors including Mubadala And C-Bridge Capital.

Q: When was the last funding round for Hasten?

Hasten closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Hasten

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Hasten

CB Rank

64581

Hasten is a pharmaceutical manufacturing company that integrates R&D, manufacturing, and commercialization.

Founded

obfuscation

Private

Venture - Series Unknown

Hefei, Anhui, China

501-1000

www.hastenpharma.com

Health Care

Hospital

Manufacturing

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

Hasten Biopharmaceutic Co., Ltd.

Also Known As

Hasten Biopharmaceutic, Haisen Biology, Heisen Biomedical

Operating Status

Active

Company Type

For Profit

About the Company

Hasten is a pharmaceutical manufacturing company that integrates R&D, manufacturing, and commercialization, and covers the entire industry chain. They are dedicated to creating China's innovative medical and health company, and they collaborate with key government agencies, medical and health professionals, and industry partners to provide

high-quality solutions, build a health management ecosystem, and benefit more patients.

Contact Email

Hasten.Communication@hastenpharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Hasten is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Has Achieved Unicorn Status

Products & Services

Lerodalcibep (HST101)

A third-generation PCSK9 inhibitor fusion protein designed for monthly subcutaneous injection to lower LDL cholesterol in patients with cardiovascular diseases and familial hypercholesterolemia.

Edarbi® (Azilsartan Medoxomil Potassium Tablets)

An angiotensin receptor blocker (ARB) used to treat adult primary hypertension by lowering blood pressure.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Hasten	2	obfuscated obfuscation	C-Bridge Capital, Mubadala	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Mubadala	Yes	Venture Round - Hasten	Mohamed Albadr
Mubadala	Yes	Venture Round - Hasten	Mohamed Albadr
Mubadala	Yes	Venture Round - Hasten	Mohamed Albadr
Mubadala	Yes	Venture Round - Hasten	Mohamed Albadr
Mubadala	Yes	Venture Round - Hasten	Mohamed Albadr